Baicalin and its nanoliposomes ameliorates nonalcoholic fatty liver disease via suppression of TLR4 signaling cascade in mice - Liu, J; Yuan, Y; Gong, X; Zhang, L; Zhou, Q; Wu, S (Int Immunopharmacol, 2020)